Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma
…, M Vanhoeij, FP Duhoux, T Gevaert… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Human epidermal growth factor receptor 2 (HER2) status is one of the major tumor characteristics
in breast cancer to guide therapy. Anti-HER2 treatment has clear survival advantages …
in breast cancer to guide therapy. Anti-HER2 treatment has clear survival advantages …
Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non–small-cell lung cancer: results of a phase II trial
S Bral, T Gevaert, N Linthout, H Versmessen… - International Journal of …, 2011 - Elsevier
PURPOSE: Validation of a prospective, risk-adapted strategy for early-stage non–small-cell
lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT). …
lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT). …
Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system
T Depuydt, D Verellen, O Haas, T Gevaert… - Radiotherapy and …, 2011 - Elsevier
PURPOSE: VERO is a novel platform for image guided stereotactic body radiotherapy.
Orthogonal gimbals hold the linac-MLC assembly allowing real-time moving tumor tracking. This …
Orthogonal gimbals hold the linac-MLC assembly allowing real-time moving tumor tracking. This …
Setup accuracy of the Novalis ExacTrac 6DOF system for frameless radiosurgery
T Gevaert, D Verellen, K Tournel, N Linthout… - International Journal of …, 2012 - Elsevier
PURPOSE: Stereotactic radiosurgery using frame-based positioning is a well-established
technique for the treatment of benign and malignant lesions. By contrast, a new trend toward …
technique for the treatment of benign and malignant lesions. By contrast, a new trend toward …
Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery
T Gevaert, D Verellen, B Engels, T Depuydt… - International Journal of …, 2012 - Elsevier
PURPOSE: To evaluate the added value of 6–degree of freedom (DOF) patient positioning
with a robotic couch compared with 4DOF positioning for intracranial lesions and to estimate …
with a robotic couch compared with 4DOF positioning for intracranial lesions and to estimate …
Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review
…, M Boussaer, M Duchateau, T Gevaert… - Radiotherapy and …, 2014 - Elsevier
Purpose To report on the first clinical application of a real-time tumor tracking (RTTT) solution
based on the Vero SBRT gimbaled linac system for treatment of moving tumors. Methods …
based on the Vero SBRT gimbaled linac system for treatment of moving tumors. Methods …
The long-and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment
…, B Engels, T Reynders, M Boussaer, T Gevaert… - Radiotherapy and …, 2018 - Elsevier
Purpose To evaluate the short and long-term variability of breathing induced tumor motion.
Materials and methods 3D tumor motion of 19 lung and 18 liver lesions captured over the …
Materials and methods 3D tumor motion of 19 lung and 18 liver lesions captured over the …
Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience
C Collen, B Ampe, T Gevaert, M Moens… - International Journal of …, 2011 - Elsevier
PURPOSE: To evaluate and compare outcomes for patients with vestibular schwannoma (VS)
treated in a single institution with linac-based stereotactic radiosurgery (SRS) or by …
treated in a single institution with linac-based stereotactic radiosurgery (SRS) or by …
[HTML][HTML] Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
J Tipanee, E Samara-Kuko, T Gevaert, MK Chuah… - Molecular Therapy, 2022 - cell.com
Allogeneic CD19-specific chimeric antigen receptor (CAR) T cells with inactivated donor T
cell receptor (TCR) expression can be used as an "off-the-shelf" therapeutic modality for …
cell receptor (TCR) expression can be used as an "off-the-shelf" therapeutic modality for …
[HTML][HTML] Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
T de Vin, B Engels, T Gevaert, G Storme, M De Ridder - Annals of oncology, 2014 - Elsevier
Background Stereotactic radiotherapy (SRT) is a safe and locally effective treatment for patients
with inoperable oligometastases. The challenge remains identifying subsets of patients …
with inoperable oligometastases. The challenge remains identifying subsets of patients …